{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:52:33Z","timestamp":1789602753851,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["724517"],"award-info":[{"award-number":["724517"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaut.2025.103444","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:55:06Z","timestamp":1750647306000},"page":"103444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-1887","authenticated-orcid":false,"given":"M.D.","family":"van den Beukel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8871-0079","authenticated-orcid":false,"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-603X","authenticated-orcid":false,"given":"S.","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4372-1973","authenticated-orcid":false,"given":"N.V.","family":"Borggreven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3709-1526","authenticated-orcid":false,"given":"S.","family":"Nugteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-8454","authenticated-orcid":false,"given":"R.B.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-032X","authenticated-orcid":false,"given":"K.A.","family":"Gelderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1166-4059","authenticated-orcid":false,"given":"A.H.","family":"de Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-4030","authenticated-orcid":false,"given":"G.M.C.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-9408","authenticated-orcid":false,"given":"P.A.","family":"van Veelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7494-3023","authenticated-orcid":false,"given":"R.","family":"Knevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-3859","authenticated-orcid":false,"given":"P.W.H.I.","family":"Parren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-2290","authenticated-orcid":false,"given":"L.A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaut.2025.103444_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib2","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"42","key":"10.1016\/j.jaut.2025.103444_bib3","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"25","key":"10.1016\/j.jaut.2025.103444_bib4","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2023","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jbspin.2012.01.008","article-title":"Citrullination under physiological and pathological conditions","volume":"79","author":"Baka","year":"2012","journal-title":"Jt. Bone Spine"},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"Shi","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.jaut.2025.103444_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03346408","article-title":"Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantation","volume":"31","author":"Buongiorno","year":"2008","journal-title":"J. Endocrinol. Investig."},{"issue":"8","key":"10.1016\/j.jaut.2025.103444_bib9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1530-0277.1998.tb03973.x","article-title":"Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant","volume":"22","author":"Thiele","year":"1998","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"10","key":"10.1016\/j.jaut.2025.103444_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0022-2275(20)37720-8","article-title":"Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine","volume":"25","author":"Steinbrecher","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2025.103444_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molimm.2021.10.010","article-title":"Circulating C1q levels in health and disease, more than just a biomarker","volume":"140","author":"van de Bovenkamp","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2025.103444_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2015.06.002","article-title":"Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency","volume":"62","author":"van Schaarenburg","year":"2015","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jaut.2025.103444_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003480","article-title":"Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association","volume":"9","author":"van den Beukel","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002079","article-title":"Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations","volume":"8","author":"Monahan","year":"2022","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.jaut.2025.103444_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107440","article-title":"Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease","volume":"9","author":"Anderson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2025.103444_bib16","article-title":"Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment","volume":"10","author":"van den Beukel","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2025.103444_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.2007.00556.x","article-title":"Complement receptors CD21 and CD35 in humoral immunity","volume":"219","author":"Roozendaal","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2025.103444_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620427","article-title":"Revisiting the coreceptor function of complement receptor type 2 (CR2, CD21); coengagement with the B-cell receptor inhibits the activation, proliferation, and antibody production of human B cells","volume":"12","author":"Kovacs","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2025.103444_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"Harris","year":"2012","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12097","article-title":"Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis","volume":"173","author":"Trouw","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/ard.2007.085688","article-title":"Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity","volume":"68","author":"Martens","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jaut.2025.103444_bib23","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.humimm.2011.09.003","article-title":"TRAF1\/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey","volume":"72","author":"Zervou","year":"2011","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10238-021-00758-0","article-title":"Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"22","author":"Ebrahimiyan","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103444_bib25","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/207691","article-title":"Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease","volume":"2011","author":"Karve","year":"2011","journal-title":"J. Amino Acids"},{"issue":"2","key":"10.1016\/j.jaut.2025.103444_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","article-title":"Autoantibodies in rheumatoid arthritis: historical background and novel findings","volume":"63","author":"Sokolova","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"20","key":"10.1016\/j.jaut.2025.103444_bib27","first-page":"2392","article-title":"Immunoglobulins against tyrosine-nitrated epitopes in coronary artery disease","volume":"126","author":"Thomson","year":"2012","journal-title":"Circulation (New York, N. Y.)"},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92630-0","article-title":"Advanced glycation end products and their receptors in serum of patients with type 2 diabetes","volume":"11","author":"Indyk","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2004.07.004","article-title":"Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine","volume":"96","author":"Ohmori","year":"2005","journal-title":"Immunol. Lett."},{"issue":"8","key":"10.1016\/j.jaut.2025.103444_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/annrheumdis-2016-210772","article-title":"Breach of autoreactive B cell tolerance by post-translationally modified proteins","volume":"76","author":"Dekkers","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jaut.2025.103444_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nprot.2010.117","article-title":"Generation of acetyllysine antibodies and affinity enrichment of acetylated peptides","volume":"5","author":"Guan","year":"2010","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.1016\/j.jaut.2025.103444_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2010.08.001","article-title":"Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis","volume":"49","author":"Duryee","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.jaut.2025.103444_bib33","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.49.10.1714","article-title":"Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor","volume":"49","author":"Nagai","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2337\/diabetes.46.1.87","article-title":"Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin","volume":"46","author":"Bobbink","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2025.103444_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2017.02.008","article-title":"Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis","volume":"80","author":"Verheul","year":"2017","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.55563\/clinexprheumatol\/0ms5pk","article-title":"Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls","volume":"39","author":"Verheul","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","article-title":"van der Helm-van Mil AH. Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?","volume":"50","author":"de Rooy","year":"2011","journal-title":"Rheumatology (Oxf.)"},{"issue":"11","key":"10.1016\/j.jaut.2025.103444_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015443","article-title":"Functional analysis of Ficolin-3 mediated complement activation","volume":"5","author":"Hein","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2025.103444_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04185.x","article-title":"Assessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus","volume":"161","author":"Rafiq","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bioinformatics\/btg382","article-title":"A global test for groups of genes: testing association with a clinical outcome","volume":"20","author":"Goeman","year":"2004","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.jaut.2025.103444_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2017.11.017","article-title":"Pitfalls in the detection of citrullination and carbamylation","volume":"17","author":"Verheul","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1194\/jlr.M200370-JLR200","article-title":"Autoimmune response to advanced glycosylation end-products of human LDL","volume":"44","author":"Virella","year":"2003","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.jaut.2025.103444_bib43","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2025.103444_bib44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jaut.2025.103444_bib45","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.41424","article-title":"Autoantibodies to malondialdehyde-acetaldehyde are detected prior to rheumatoid arthritis diagnosis and after other disease specific autoantibodies","volume":"72","author":"Mikuls","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2025.103444_bib46","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jaut.2025.103444_bib47","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acs.biochem.5b00777","article-title":"Identification of C1q as a binding protein for advanced glycation end products","volume":"55","author":"Chikazawa","year":"2016","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jcm4010018","article-title":"Role of factor H and related proteins in regulating complement activation in the macula, and relevance to age-related macular degeneration","volume":"4","author":"Clark","year":"2015","journal-title":"J. Clin. Med."},{"issue":"7367","key":"10.1016\/j.jaut.2025.103444_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature10449","article-title":"Complement factor H binds malondialdehyde epitopes and protects from oxidative stress","volume":"478","author":"Weismann","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaut.2025.103444_bib51","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1038\/s41467-019-10766-0","article-title":"Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies","volume":"10","author":"Irmscher","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2025.103444_bib52","series-title":"Factor H-Related Protein 3 (FHR-3) Inhibits Factor H Binding to Pentraxins and Malondialdehyde Epitopes, and Activates the Alternative Pathway via C3b Binding","author":"\u00c1d\u00e1m","year":"2016"},{"key":"10.1016\/j.jaut.2025.103444_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.769242","article-title":"Complement factor H-related 3 enhanced inflammation and complement activation in human RPE cells","volume":"12","author":"Schafer","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2025.103444_bib54","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.4049\/jimmunol.1701641","article-title":"FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces","volume":"200","author":"Rudnick","year":"2018","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib55","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.4049\/jimmunol.1000522","article-title":"Complement-dependent transport of antigen into B cell follicles","volume":"185","author":"Gonzalez","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib56","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.181.5.2953","article-title":"Comparative functional evolution of human and mouse CR1 and CR2","volume":"181","author":"Jacobson","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103444_bib57","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4049\/jimmunol.1600053","article-title":"FHR3 blocks C3d-mediated coactivation of human B cells","volume":"197","author":"Buhlmann","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103444_bib58","article-title":"Genetic variants of complement factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and response to intravitreal anti-VEGF treatment in patients with exudative age-related macular degeneration","volume":"58","author":"Kubicka-Trzaska","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"21","key":"10.1016\/j.jaut.2025.103444_bib59","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jaut.2025.103444_bib60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00296-022-05089-1","article-title":"Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study","volume":"42","author":"Kosturkova","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.jaut.2025.103444_bib61","first-page":"280","article-title":"Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients","volume":"24","author":"Radanova","year":"2015","journal-title":"Lupus (Basingstoke)"},{"key":"10.1016\/j.jaut.2025.103444_bib62","article-title":"Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2025.103444_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102163","article-title":"Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis","volume":"9","author":"Stoop","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2025.103444_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004131","article-title":"Differences in avidity of anti-post-translationally modified protein antibodies in mouse models and rheumatoid arthritis patients: not one-size-fits-all","volume":"10","author":"van der Meulen","year":"2024","journal-title":"RMD Open"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:10:30Z","timestamp":1753222230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":64,"alternative-id":["S0896841125000897"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103444","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103444"}}